Drug Enforcement D-0096-2023

Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.

Status

Terminated

Classification

Class III

Report Date

January 11, 2023

Termination Date

December 5, 2023

Product Information

Product description
Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, Maryland 21801, NDC 59746-113-06
Product quantity
14,061 bottles
Reason for recall
Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA.

Location & Firm

Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.
Address
207 Kiley Dr, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0096-2023
Event ID
91412
Recall initiation date
December 27, 2022
Center classification date
January 5, 2023
Code info
Lot#: 21P0336, Exp: 04/2023
More code info